Bright Minds Biosciences Inc.
DRUG
CNSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -6.36M | -2.40M | -771.90K | -2.05M | -2.64M |
| Total Depreciation and Amortization | 56.50K | 23.20K | 20.90K | 18.80K | 18.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.06M | -318.00K | -593.50K | 634.40K | 930.30K |
| Change in Net Operating Assets | -387.10K | -224.90K | -484.30K | 26.60K | -232.30K |
| Cash from Operations | -5.63M | -2.92M | -1.83M | -1.37M | -1.92M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -97.90K | -94.30K | -91.70K | -89.90K | -87.60K |
| Issuance of Common Stock | 49.82M | 49.81M | 49.56M | 900.00K | 900.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 2.51M | 2.51M | 2.51M | 300.00 | 0.00 |
| Cash from Financing | 37.30M | 37.30M | 37.13M | 595.80K | 597.00K |
| Foreign Exchange rate Adjustments | 607.30K | 1.19M | 1.20M | 8.40K | -125.70K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 32.28M | 35.57M | 36.50M | -761.30K | -1.45M |